valneva se glp-1 receptor agonist weight management diabetes treatments New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within Agonists GLP-1 receptor agonists are increasingly

See how GLP-1s are reshaping diabetes & obesity care.

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

Get Guidance from Set Point.

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.

Carey MD Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore

Industry Report Examines What Consumers Are Searching For After Seeing Weight Loss Patch Ads, What These Products Actually Contain, and How to Evaluate Non-Prescription Options Entering 2026NEW YORK, Dec